» Articles » PMID: 34995294

Association of Genetic Variations in ACE2, TIRAP and Factor X with Outcomes in COVID-19

Overview
Journal PLoS One
Date 2022 Jan 7
PMID 34995294
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can manifest with varying disease severity and mortality. Genetic predisposition influences the clinical course of infectious diseases. We investigated whether genetic polymorphisms in candidate genes ACE2, TIRAP, and factor X are associated with clinical outcomes in COVID-19.

Methods: We conducted a single-centre retrospective cohort study. All patients who visited the emergency department with SARS-CoV-2 infection proven by polymerase chain reaction were included. Single nucleotide polymorphisms in ACE2 (rs2285666), TIRAP (rs8177374) and factor X (rs3211783) were assessed. The outcomes were mortality, respiratory failure and venous thromboembolism. Respiratory failure was defined as the necessity of >5 litres/minute oxygen, high flow nasal oxygen suppletion or mechanical ventilation.

Results: Between March and April 2020, 116 patients (35% female, median age 65 [inter quartile range 55-75] years) were included and treated according to the then applicable guidelines. Sixteen patients (14%) died, 44 patients (38%) had respiratory failure of whom 23 required endotracheal intubation for mechanical ventilation, and 20 patients (17%) developed venous thromboembolism. The percentage of TIRAP polymorphism carriers in the survivor group was 28% as compared to 0% in the non-survivor group (p = 0.01, Bonferroni corrected p = 0.02). Genotype distribution of ACE2 and factor X did not differ between survivors and non-survivors.

Conclusion: This study shows that carriage of TIRAP polymorphism rs8177374 could be associated with a significantly lower mortality in COVID-19. This TIRAP polymorphism may be an important predictor in the outcome of COVID-19.

Citing Articles

Association of ACE2 and TMPRSS2 genes variants with disease severity and most important biomarkers in COVID-19 patients in Bosnia and Herzegovina.

Meseldzic N, Prnjavorac B, Dujic T, Malenica M, Glamoclija U, Prnjavorac L Croat Med J. 2024; 65(3):220-231.

PMID: 38868968 PMC: 11157263.


Host genetic polymorphisms involved in long-term symptoms of COVID-19.

Udomsinprasert W, Nontawong N, Saengsiwaritt W, Panthan B, Jiaranai P, Thongchompoo N Emerg Microbes Infect. 2023; 12(2):2239952.

PMID: 37497655 PMC: 10392286. DOI: 10.1080/22221751.2023.2239952.


Influence of polymorphic variations of IFNL, HLA, and IL-6 genes in severe cases of COVID-19.

Araujo A, Sgorlon G, Aguiar L, Cidrao M, Teixeira K, Salcedo J Exp Biol Med (Maywood). 2023; 248(9):787-797.

PMID: 37452704 PMC: 10350587. DOI: 10.1177/15353702231181343.


Genetics of COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review.

Tziastoudi M, Cholevas C, Stefanidis I, Theoharides T Ann Clin Transl Neurol. 2022; 9(11):1838-1857.

PMID: 36204816 PMC: 9639636. DOI: 10.1002/acn3.51631.


Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity.

Gupta K, Kaur G, Pathak T, Banerjee I Gene. 2022; 844:146790.

PMID: 35987511 PMC: 9384365. DOI: 10.1016/j.gene.2022.146790.


References
1.
Imai Y, Kuba K, Neely G, Yaghubian-Malhami R, Perkmann T, van Loo G . Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008; 133(2):235-49. PMC: 7112336. DOI: 10.1016/j.cell.2008.02.043. View

2.
Foley J, Conway E . Cross Talk Pathways Between Coagulation and Inflammation. Circ Res. 2016; 118(9):1392-408. DOI: 10.1161/CIRCRESAHA.116.306853. View

3.
Du L, Kao R, Zhou Y, He Y, Zhao G, Wong C . Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity. Biochem Biophys Res Commun. 2007; 359(1):174-9. PMC: 2323977. DOI: 10.1016/j.bbrc.2007.05.092. View

4.
Choby J, Monteith A, Himmel L, Margaritis P, Shirey-Rice J, Pruijssers A . A Phenome-Wide Association Study Uncovers a Pathological Role of Coagulation Factor X during Infection. Infect Immun. 2019; 87(5). PMC: 6479028. DOI: 10.1128/IAI.00031-19. View

5.
Kawasaki T, Kawai T . Toll-like receptor signaling pathways. Front Immunol. 2014; 5:461. PMC: 4174766. DOI: 10.3389/fimmu.2014.00461. View